Patent details

EP1265928 Title: ULTRA HIGH AFFINITY RSV NEUTRALIZING ANTIBODIES

Basic Information

Publication number:
EP1265928
PCT Application Number:
PCT/US/2001/002618
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019033521
PCT Publication Number:
WO/2001/055217
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ULTRA HIGH AFFINITY RSV NEUTRALIZING ANTIBODIES
French Title of Invention:
ANTICORPS NEUTRALISANT RSV D'AFFINITE ULTRA-ELEVEE
German Title of Invention:
RSV NEUTRALISIERENDE ANTIKÖRPER MIT SEHR HOHEN AFFINITÄT
SPC Number:

Dates

Filing date:
26/01/2001
Grant date:
21/07/2010
EP Publication Date:
21/07/2010
PCT Publication Date:
02/08/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/12/2002
EP B1 Publication Date:
21/07/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/01/2013
Expiration date:
26/01/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/01/2001
 
 

Name:
MedImmune LLC
Address:
One MedImmune Way, Gaithersburg, MD 20878, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
08/09/2010
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
JOHNSON Leslie, S.
Address:
United States (US)

2

Name:
YOUNG James, F.
Address:
United States (US)

3

Name:
KOENIG Scott
Address:
United States (US)

4

Name:
HUSE William, D.
Address:
United States (US)

5

Name:
WATKINS Jeffry, D.
Address:
United States (US)

6

Name:
WU Herren
Address:
United States (US)

Priority

Priority Number:
178426 P
Priority Date:
27/01/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/10;
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56